The Triple Negative Breast Cancer Battlefield

New Tools for Testing Therapies How do we attack an enemy we can’t even see? This is the challenge doctors and scientists face when they come head-to-head with Triple Negative Breast Cancer (TNBC). This subtype is called “triple negative” because it lacks any of the three principle markers found on other forms of breast cancer: […]